These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 33079568)

  • 21. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
    Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
    Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of Gut Microbiota in Cardiovascular Diseases.
    Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
    Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health.
    Jia B; Park D; Hahn Y; Jeon CO
    Gut Microbes; 2020 Sep; 11(5):1300-1313. PubMed ID: 32329665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of intestinal microbiota in cardiovascular disease.
    Jin M; Qian Z; Yin J; Xu W; Zhou X
    J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gutting TMA to Save the Heart.
    Crothers J; Bry L
    Cell Host Microbe; 2018 Oct; 24(4):470-471. PubMed ID: 30308152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ.
    Yang X; Zhang X; Yang W; Yu H; He Q; Xu H; Li S; Shang Z; Gao X; Wang Y; Tong Q
    Front Endocrinol (Lausanne); 2021; 12():749125. PubMed ID: 34552566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics.
    Moludi J; Maleki V; Jafari-Vayghyan H; Vaghef-Mehrabany E; Alizadeh M
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):927-939. PubMed ID: 31894861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble Dietary Fiber Reduces Trimethylamine Metabolism via Gut Microbiota and Co-Regulates Host AMPK Pathways.
    Li Q; Wu T; Liu R; Zhang M; Wang R
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28884952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease.
    Busnelli M; Manzini S; Chiesa G
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31892152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials.
    Myhrstad MCW; Tunsjø H; Charnock C; Telle-Hansen VH
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32210176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome.
    Markowiak-Kopeć P; Śliżewska K
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
    Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
    J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
    Manolis AA; Manolis TA; Melita H; Manolis AS
    Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
    Duttaroy AK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease.
    Rodríguez-Morató J; Matthan NR
    Curr Atheroscler Rep; 2020 Jul; 22(9):47. PubMed ID: 32681421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cranberries attenuate animal-based diet-induced changes in microbiota composition and functionality: a randomized crossover controlled feeding trial.
    Rodríguez-Morató J; Matthan NR; Liu J; de la Torre R; Chen CO
    J Nutr Biochem; 2018 Dec; 62():76-86. PubMed ID: 30269035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of microbially derived short-chain fatty acids on intestinal homeostasis, metabolism, and neuropsychiatric disorder.
    Xiao S; Jiang S; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(2):589-601. PubMed ID: 31865438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.